Bordetella pertussis engineered strain, preparation method and application thereof
CN121653033BActive Publication Date: 2026-07-24SHANGHAI YUGUAN BIOTECH CO LTD
Patent Information
- Application Number
- CN202610179036.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2026-02-09
- Publication Date
- 2026-07-24
- Estimated Expiration
- 2046-02-09
AI Technical Summary
Technical Problem
Bordetella pertussis is unable to efficiently secrete outer membrane vesicles (OMV), which limits the development of pertussis OMV vaccines and the effectiveness of immune responses.
Method used
OMV production was increased by introducing the expression of lpxD protein derived from Pseudomonas jinjuensis into Bordetella pertussis. The specific method involved constructing a nucleic acid construct and performing gene editing in Bordetella pertussis to express the lpxD protein to enhance OMV secretion.
Benefits of technology
It significantly improved the yield and quality of Bordetella pertussis OMV, enhanced the effectiveness of the immune response, and promoted the development of a Bordetella pertussis OMV vaccine.
✦ Generated by Eureka AI based on patent content.
Smart Images

Figure CN121653033B_ABST
Abstract
This invention discloses an engineered strain of Bordetella pertussis, its preparation method, and its application. The engineered Bordetella pertussis strain and the Bordetella pertussis strain (…) Bordetella pertussis Compared to ), expressing Jinzhou Pseudomonas ( Pseudomonas jinjuensis The lpxD protein is derived from [source missing]. The strain of Bordetella pertussis engineered strain provided by this invention has a significant effect on increasing OMV production, which will promote the development of Bordetella pertussis OMV vaccines.
Need to check novelty before this filing date? Find Prior Art
Citation Information
Patent Citations
OmpA mutation enhanced OMV production in Bordetella pertussis
CN116438193A
Modified Bordetella pertussis strains
CN118853525B
Vaccines for the prevention of infections with Bordetella
US9623102B2
Genetically intervened bordetella pertussis strain as well as preparation method and application thereof
CN121271771A